StockNews.com Initiates Coverage on OncoCyte (NASDAQ:OCX) :

Investment analysts at StockNews.com assumed coverage on shares of OncoCyte (NASDAQ:OCX – Get Free Report) in a note issued to investors on Sunday. The firm set a “sell” rating on the stock. OncoCyte Stock Performance OCX stock opened at $2.98 on Friday. OncoCyte has a one year low of $2.08 and a one year high […]

Related Keywords

United States , , Cubist Systematic Strategies , Renaissance Technologies , Oncocyte Company Profile , Raymond James Financial Services Advisors Inc , Balyasny Asset Management , Oncocyte Corporation , Get Free Report , Systematic Strategies , James Financial Services Advisors , Asset Management , Cyte Corporation , Oncocyte Daily , Oncocyte , Nasdaq Ocx , Socx , Medical , Initiated Coverage , Stocknews Com ,